Our UHN programs and services are among the most advanced in the world. We have grouped our physicians, staff, services and resources into 10 medical programs to meet the needs of our patients and help us make the most of our resources.
University Health Network is a health care and medical research organization in Toronto, Ontario, Canada. The scope of research and complexity of cases at UHN has made us a national and international source for discovery, education and patient care.
Our 10 medical programs are spread across eight hospital sites – Princess Margaret, Toronto General, Toronto Rehab’s five sites, Toronto Western – as well as our education programs through the Michener Institute of Education at UHN. Learn more about the services, programs and amenities offered at each location.
Maps & Directions
Find out how to get to and around our nine locations — floor plans, parking, public transit, accessibility services, and shuttle information.
Ways You Can Help
Being touched by illness affects us in different ways. Many people want to give back to the community and help others. At UHN, we welcome your contribution and offer different ways you can help so you can find one that suits you.
The Newsroom is the source for media looking for information about UHN or trying to connect with one of our experts for an interview. It’s also the place to find UHN media policies and catch up on our news stories, videos, media releases, podcasts and more.
Air Date: October 12, 2021 | Length: 54:52
Share this episode:
Season Three of UHN's two-time Canadian Podcast Awards nominated "Behind the Breakthrough" launches October 12, 2021, with a special COVID-19 episode featuring a provocative and wide-ranging conversation with UHN Executive Vice President of Science and Research, Dr. Brad Wouters. Dr. Wouters highlights some of the UHN Research teams' leading-edge COVID-19 treatments and discoveries, including world-first investigations that demonstrated Heparin prevents deadly blood clots in COVID patients with mild symptoms, and, a third dose of the COVID vaccine dramatically improves protection against the virus for immune-compromised transplant patients.
Dr. Wouters also discusses the triumph of basic science to create the COVID-19 mRNA-based vaccines, and, how and when does this pandemic end. Plus, he speaks to a challenge he sees on the horizon for medical research in Canada — how to maintain the tremendous public profile and support it now enjoys once the pandemic fades away.
Dr. Brad Wouters is an internationally recognized leader and cancer researcher. He became Executive Vice President of Science and Research at UHN in 2016 and prior to that served as the Interim Director of Research at the Princess Margaret Cancer Centre since 2014. He joined UHN in 2008 as Senior Scientist and Director of the Princess Margaret Hypoxia Program, and has held faculty appointments at the University of Toronto in the Department of Medical Biophysics and the Department of Radiation Oncology since that time. Prior to joining UHN, Dr. Wouters was Professor and Head of Experimental Radiation Oncology at Maastricht University in the Netherlands. As EVP of Science and Research, Dr. Wouters is focused on creating an environment that incentivizes, facilitates, and rewards excellence in basic, translational, and clinical research across all elements of UHN.